MedTrace Logo

Ideal Marker for Targeted Axillary Dissection

NCT04580251 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-09-07

No results posted yet for this study

Summary

A multicentre prospective comparative study, comparing the use of various markers (magnetic marker Magseed, iodine seed 125I, carbon suspension) for marking a pathological lymph node in patients with breast carcinoma prior to neoadjuvant therapy and subsequent surgical treatment consisting of targeted axillary dissection.

Conditions

Interventions

PROCEDURE

Targeted axillary dissection

The surgical treatment procedure of targeted axillary dissection performed in patients in whom the pathological lymph nodes have been marked using the examined and compared markers (magnetic marker Magseed, iodine seed 125I, carbon suspension)

Sponsors & Collaborators

  • Silesian Hospital in Opava

    collaborator OTHER

  • Masaryk Memorial Cancer Institute

    collaborator OTHER

  • EUC Clinic in Zlín

    collaborator UNKNOWN

  • Institute for the Care of Mother and Child, Prague, Czech Republic

    collaborator OTHER

  • University of Ostrava

    collaborator OTHER

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Jan Žatecký, MD · Silesian Hospital in Opava

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-01-01
Completion
2023-05-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04580251 on ClinicalTrials.gov